IRON ▲ +37.3% - Disc Medicine, Inc. $IRON Disc Medicine: Announces Proposed $350 Million Stock Offering Following Positive Phase 3 APOLLO Results ? • Offering includes newly issued common shares and pre-funded warrants, with a 30-day underwriter option for an additional $52.5M. • Proceeds will support clinical development and potential commercialization of bitopertin for EPP and XLP. • Transaction could raise up to $402.5M if fully exercised, potentially diluting existing shareholders. Pricing and completion remain subject to market conditions. 19-OCT-2026 04:03 PM ET